Sponsored by:

Presented by:

Tissue-based profiling for confident decisions in immuno-oncology

Wednesday, September 12, 2018
8AM PDT | 11AM EDT | 4PM BST | 5PM CEST

If you’ve already registered, please click here to log in to the webcast.

This webcast will highlight benefits of standardizing tissue profiling for decision making in drug development and trial designs in immuno-oncology.

During the webcast:
  • Discover the challenges in comparing results across different clinical studies that result from inconsistent biomarker strategies
  • A harmonized tissue profiling strategy is introduced as a promising solution and platform trials are considered as an emerging paradigm in immuno-oncology
  • Gain and understand if and how the standardized IO profiling solution from Definiens will help you to achieve your objectives
  • Learn about best practices in tissue-based immune profiling that can be transferred to situations that cannot be covered with a standardized offering
  • Speak to the presenters in a live Q&A session following the presentation.

This webcast has been produced on behalf of the sponsor who retains sole responsibility for content. About this content
Presenter
Dr. Florian Leiß
Director Profiling & Dx
Definiens
View Biography
Presenter
Dr. Moritz Widmaier
Solution Manager Profiling
Definiens
View Biography
Presenter
Dr. Jayshan Carpen
Moderator
Nature Research
View Biography

Registration details:

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

(*) denotes required form field(s)

Submit